Zobrazeno 1 - 10
of 232
pro vyhledávání: '"García Barberán, V."'
Autor:
Cabezas-Camarero S; Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain., Pérez-Alfayate R; Neurosurgery Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Gómez Del Pulgar ME; Molecular Oncology Laboratory, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain., Cabrera-Martin MN; Nuclear Medicine Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain., Casado-Fariñas I; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Pérez-Segura P; Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 377-383.
Autor:
Martínez-Rodríguez, A., Gómez del Pulgar, M., López-Cade, I., Paz-Cabezas, M., Lorca, V., García-barberán, V.
Publikováno v:
In The Journal of Liquid Biopsy November 2023 1 Supplement
Autor:
Fuentes-Antrás J; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.; Experimental Therapeutics Unit, Hospital Clínico San Carlos, IDISSC and CIBERONC, 28040 Madrid, Spain., Martínez-Rodríguez A; Molecular Oncology Laboratory, IdISSC, 28040 Madrid, Spain., Guevara-Hoyer K; Department of Clinical Immunology, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.; Cancer Immunomonitoring and Immune-Mediated Diseases Unit, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain., López-Cade I; Experimental Therapeutics Unit, Hospital Clínico San Carlos, IDISSC and CIBERONC, 28040 Madrid, Spain.; Molecular Oncology Laboratory, IdISSC, 28040 Madrid, Spain., Lorca V; Molecular Oncology Laboratory, IdISSC, 28040 Madrid, Spain., Pascual A; Department of Pathology, Hospital Clínico San Carlos, 28040 Madrid, Spain., de Luna A; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain., Ramírez-Ruda C; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain., Swindell J; Medical Affairs Division, Sysmex Inostics, Inc., Baltimore, MD 21205, USA., Flores P; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain., Lluch A; INCLIVA Research Institute, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain., Cescon DW; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5S A18, Canada., Pérez-Segura P; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain., Ocaña A; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.; Experimental Therapeutics Unit, Hospital Clínico San Carlos, IDISSC and CIBERONC, 28040 Madrid, Spain., Jones F; Medical Affairs Division, Sysmex Inostics, Inc., Baltimore, MD 21205, USA., Moreno F; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, IdISSC, 28040 Madrid, Spain., García-Sáenz JÁ; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 13; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 13.
Autor:
Cabezas-Camarero S; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain., Benítez-Fuentes JD; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain., Sotelo MJ; Medical Oncology Department, Aliada Cancer Center, Lima 15036, Peru.; Medical Oncology Department, Clínica San Felipe, Lima 15072, Peru.; Medical Oncology Department, Hospital María Auxiliadora, Lima 15801, Peru., Plaza JC; Pathology Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Encinas-Bascones A; Maxillofacial Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., De-la-Sen Ó; Maxillofacial Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Falahat F; Maxillofacial Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Gimeno-Hernández J; Otolaryngology-Head and Neck Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Gómez-Serrano M; Otolaryngology-Head and Neck Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Puebla-Díaz F; Radiation Oncology Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., De-Pedro-Marina M; Maxillofacial Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Iglesias-Moreno M; Maxillofacial Surgery Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Pérez-Segura P; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Apr 24; Vol. 15 (9). Date of Electronic Publication: 2023 Apr 24.
Autor:
López de Sá A; Servicio de Oncología Médica, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., de Luna A; Servicio de Oncología Médica, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., Antoñanzas M; Servicio de Oncología Médica, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., García-Barberán V; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., Moreno-Anton F; Servicio de Oncología Médica, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., García-Sáenz JA; Servicio de Oncología Médica, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Dec 02; Vol. 12, pp. 997346. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
Autor:
López-Cade I; Experimental Therapeutics Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Cabañas Morafraile E; Center for Biological Research, Margarita Salas Centro de Investigaciones Biologicas (CIB)-Consejo Superior de Investigaciones Cientificas (CSIC), Spanish National Research Council, Madrid, Spain., Díaz-Tejeiro C; Experimental Therapeutics Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Saiz-Ladera C; Experimental Therapeutics Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Sanvicente A; Experimental Therapeutics Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Pérez Segura P; Medical Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Pandiella A; Instituto de Biología Molecular y Celular del Cáncer [IBMCC-Centro de Investigacion del Cancer (CIC)], Instituto de Investigación Biomédica de Salamanca (IBSAL), Consejo Superior de Investigaciones Científicas (CSIC) Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; 2ndDepartment of Pediatrics, Semmelweis University, Budapest, Hungary.; Termeszettudomanyi Kutatokozpont (TTK) Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary., Ocaña A; Experimental Therapeutics Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain.; Translational Oncology Laboratory, Translational Research Unit, Albacete University Hospital, Albacete, Spain.; Centro Regional de Investigaciones Biomédicas, Castilla-La Mancha University (CRIB-UCLM), Albacete, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Sep 01; Vol. 12, pp. 975437. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).
Autor:
Cabezas-Camarero, S., Pérez-Alfayate, R., García-Barberán, V., Gandía, M., García-Feijóo, P., López-Cade, I., Casado-Fariñas, I., Cerón, N., Sotelo Lezama, M.J., Pérez Segura, P.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S666-S667
Autor:
Cabezas-Camarero S; Head & Neck Cancer, Neuro-Oncology and Genetic Counseling Unit, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Paseo del Profesor Martín Lagos S/N, 28040 Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Pérez-Alfayate R; Department of Neurosurgery, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Casado-Fariñas I; Pathology Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain., Sloane H; Medical affairs Division, Sysmex Inostics, Inc., Baltimore, MD 21205, USA., Jones FS; Medical affairs Division, Sysmex Inostics, Inc., Baltimore, MD 21205, USA., Pérez-Segura P; Head & Neck Cancer, Neuro-Oncology and Genetic Counseling Unit, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Paseo del Profesor Martín Lagos S/N, 28040 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jun 11; Vol. 14 (12). Date of Electronic Publication: 2022 Jun 11.
Autor:
Cabezas-Camarero S; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Calle Profesor Martin Lagos S/N, 28040, Madrid, Spain., Pérez-Alfayate R; Department of Neurosurgery, Instituto de Neurociencias, Hospital Clínico Universitario San Carlos, Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Polidura MC; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Gómez-Ruiz MN; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Casado-Fariñas I; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Subhi-Issa IA; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Hernández JCP; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Garre P; Molecular Diagnosis Unit, Clinical Chemistry Department, IML, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clinico Universitario San Carlos, Madrid, Spain., Díaz-Millán I; Research Nurse, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Pérez-Segura P; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jun 08; Vol. 14, pp. 17588359221100863. Date of Electronic Publication: 2022 Jun 08 (Print Publication: 2022).
Autor:
Cabezas-Camarero, S., Garcia-Barberan, V., Casado-Fariñas, I., Pérez-Alfayate, R., Lopez Cade, I., Tejerina-Peces, J., Perez-Segura, P.
Publikováno v:
In Annals of Oncology December 2021 32 Supplement 7:S1387-S1387